Artivion (AORT) Non-Current Deffered Revenue (2012 - 2026)
Artivion (AORT) posted Non-Current Deffered Revenue of $9.7 million for Q1 2026, up 2.9% on a QoQ basis from $9.5 million in Q4 2025, and up 20.67% year-over-year from $8.1 million in Q1 2025.
Artivion (AORT) Non-Current Deffered Revenue (2012 - 2026) Analysis & Trends
Artivion's Non-Current Deffered Revenue history runs 15 years deep, the most recent figure standing at $9.7 million for Q1 2026.
- Quarterly Non-Current Deffered Revenue rose 20.67% year-over-year to $9.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 million (up 20.67% YoY) and the FY2025 annual result came in at $9.5 million, up 18.3% from the prior year.
- Non-Current Deffered Revenue was $9.7 million for Q1 2026 at Artivion, up from $9.5 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $9.7 million in Q1 2026 and bottomed at $5.1 million in Q3 2022.
- A 5-year average of $7.3 million and a median of $7.4 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue retreated 8.78% — and 2023, when it advanced 27.12%.
- Artivion's Non-Current Deffered Revenue stood at $5.5 million in 2022, then climbed by 24.36% to $6.8 million in 2023, then gained by 17.65% to $8.0 million in 2024, then rose by 18.3% to $9.5 million in 2025, then rose by 2.9% to $9.7 million in 2026.
- Business Quant data shows AORT's Non-Current Deffered Revenue at $9.7 million in Q1 2026, $9.5 million in Q4 2025, and $9.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | 9.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.74 Mn |
| Dec 31, 2025 | 9.46 Mn |
| Sep 30, 2025 | 9.19 Mn |
| Jun 30, 2025 | 8.73 Mn |
| Mar 31, 2025 | 8.07 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Sep 30, 2024 | 7.93 Mn |
| Jun 30, 2024 | 7.46 Mn |
| Mar 31, 2024 | 7.45 Mn |
| Dec 31, 2023 | 6.80 Mn |
| Sep 30, 2023 | 6.46 Mn |
| Jun 30, 2023 | 6.54 Mn |
| Mar 31, 2023 | 6.13 Mn |
| Dec 31, 2022 | 5.47 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 5.15 Mn |
| Mar 31, 2022 | 5.77 Mn |
| Dec 31, 2021 | 5.95 Mn |
| Sep 30, 2021 | 5.57 Mn |
| Jun 30, 2021 | 5.50 Mn |